PharmaJet Highlights Partner Data Showing Enhanced Immune Response with Needle-Free Vaccine Delivery PharmaJet, a medical technology company pioneering innovative approaches to injectable drug delivery, will unveil compelling new data from ongoing DNA cancer vaccine trials utilizing its proprietary needle-free injection…
Rigaku Partners with Spera Pharma to Advance Drug Development In a move poised to reshape the landscape of drug discovery and pharmaceutical development, Rigaku Corporation—a leading scientific instrumentation manufacturer—and SPERA PHARMA, Inc., a cutting-edge contract development and manufacturing organization (CDMO)—have…
EveryONE Medicines Names Michelle L. Mellion, MD, as New Chief Medical Officer EveryONE Medicines, a trailblazing biotech company transforming the way individualized therapies are developed for children suffering from ultra-rare and life-threatening neurodegenerative diseases, has announced the appointment of Michelle…
ACIP Backs Pfizer’s RSV Vaccine ABRYSVO for At-Risk Adults Aged 50–59 Pfizer Inc. (NYSE: PFE) has taken a significant step forward in the effort to combat respiratory syncytial virus (RSV) infections among U.S. adults, as the U.S. Centers for Disease…
n-Lorem Foundation Celebrates Five Years of Innovation for Nano-Rare Diseases In an era where access to highly specialized medical treatments is often hindered by costs, timelines, and logistical constraints, the n-Lorem Foundation stands as a unique and revolutionary force within…
Atelerix Partners with MineBio to Distribute Cell Preservation Solutions in China UK-based biotech innovator Atelerix partners with MineBio to bring next-generation ambient-temperature cell preservation to the world’s fastest-growing biopharma market. In a major step toward transforming the logistics of biological…
Spectrum Vascular Appoints New Executive Leadership Team Spectrum Vascular, a fast-growing provider of vascular access and medication management products designed to reduce healthcare-associated infections (HAIs), has announced the appointment of two high-impact leaders to its executive team. Ken Miller has…
Soleo Health Named Exclusive Specialty Pharmacy for Qfitlia™ in Hemophilia Treatment Bringing a first-in-class antithrombin-lowering therapy to patients with hemophilia A or B, Soleo Health reinforces its leadership in specialty pharmacy services through a strategic collaboration with Sanofi. In a…
Aulos Bioscience Begins Phase 2 Dosing of AU-007 and Nivolumab Combo for Melanoma Immuno-oncology innovator Aulos Bioscience has initiated dosing in a new cohort of its ongoing Phase 1/2 clinical trial, marking a significant step forward in the development of…
Bruker Enhances IR Biotyper® for Hospital Hygiene with NGS Reflex Testing At the ESCMID Global 2025 conference, Bruker’s Microbiology and Infection Diagnostics division made a major announcement regarding the expansion of its microbiology solutions to include Next-Generation Sequencing (NGS) applications.…
Amneal Pharmaceuticals Commits $1.5 Million to Support Parkinson’s Disease Patients During Awareness Month In a powerful show of solidarity with the Parkinson’s community, Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), a global biopharmaceutical company dedicated to improving lives through the development and…
Avanzanite Bioscience Appoints Sotiris Botozis as Managing Director for Southern Europe Amid Strategic Expansion and Unprecedented Growth Avanzanite Bioscience BV, a rapidly growing player in the European life sciences and orphan drug commercialization landscape, has announced the appointment of Sotiris…